Why the study?
Does postoperative cTnI better predict 1-year cardiovascular outcomes compared to CK-MB and hs-CRP in patients undergoing elective vascular surgery?
Does postoperative cTnI better predict 1-year cardiovascular outcomes compared to CK-MB and hs-CRP in patients undergoing elective vascular surgery?
Postoperative cTnI is superior to CK-MB and hs-CRP for predicting 1-year cardiovascular events in patients undergoing elective vascular surgery.
Answers are grounded in this paper and cite their sources.
May aid postoperative risk stratification after vascular surgery; hypothesis-generating pending prospective validation.
OBJECTIVE: This study evaluated comparatively the predictive value of postoperative cardiac troponin I (cTnI), creatinine kinase (CK)-MB, and high-sensitivity C-reactive protein (hs-CRP) in 1-year cardiovascular mortality and morbidity in patients undergoing elective vascular surgery. METHODS: A total of 295 consecutive patients undergoing elective noncardiac vascular surgery were prospectively followed-up over a period of 12 months. The levels of cTnI, CK-MB, and hs-CRP were measured preoperatively and 24 h after operation. The primary endpoint was the composite of cardiovascular death, nonfatal acute myocardial infarction, ischemic stroke, and unstable angina. RESULTS: The primary endpoints occurred in 11 patients (3.8%). Receiver operating characteristic curve analysis showed that postoperative cTnI was a strong predictor of a cardiovascular event during 1-year follow-up (area under the curve, 0.852; P<0.001). Areas under the curve for hs-CRP and for CK-MB were 0.734 (P=0.008) and 0.494 (P=0.947). A threshold cTnI value of 0.4 ng/ml was highly associated with the occurrence of a cardiovascular event, with a sensitivity of 80% and specificity of 81%. Furthermore, cTnI levels provided a significantly better prediction than CK-MB levels (P=0.009) and tended to be superior to hs-CRP (P=0.2). CONCLUSION: Postoperative cTnI levels seem to be superior to CK-MB and hs-CRP levels for the prediction of 1-year cardiovascular mortality and morbidity in patients undergoing elective vascular surgery.
No takes yet. Share an insight, caveat, or question.
Kouvelos et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: